M3-Brigade Acquisition VI Corp. Units
NASDAQ:MBVIUShell Companies
+$0.00 today
- Market cap
- $353.63M
- Beta
- 0.09
Volume 0.00M
Average 0.00M
Price history
M3-Brigade Acquisition VI Corp. Units SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-0.10%
Period high
$10.34
Period low
$10.11
Latest
$10.25
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 3 | May 19, 2026 | May 19, 2026 | |
| 10-Q | May 15, 2026 | May 15, 2026 | |
| 10-K | Mar 17, 2026 | Mar 16, 2026 | |
| SC 13G | Feb 12, 2026 | Feb 12, 2026 | |
| 3 | Dec 12, 2025 | Dec 12, 2025 | |
| 8-K | Dec 5, 2025 | Dec 4, 2025 | |
| 10-Q | Nov 13, 2025 | Nov 13, 2025 | |
| SC 13G | Nov 12, 2025 | Nov 12, 2025 | |
| 8-K | Oct 16, 2025 | Oct 16, 2025 | |
| 10-Q | Oct 8, 2025 | Oct 8, 2025 | |
| 8-K | Sep 4, 2025 | Sep 4, 2025 | |
| 8-K | Sep 2, 2025 | Sep 2, 2025 | |
| 424B4 | Aug 27, 2025 | Aug 27, 2025 | |
| 3 | Aug 26, 2025 | Aug 27, 2025 | |
| 3 | Aug 26, 2025 | Aug 27, 2025 |
Competitors
Who does M3-Brigade Acquisition VI Corp. Units compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
K&F Growth Acquisition Corp. II Class A Ordinary shares
NASDAQ:KFII
Market cap
$414.15M
M3-Brigade Acquisition V Corp. Class A Ordinary shares
NASDAQ:MBAV
Market cap
$389.20M
Cantor Equity Partners II, Inc. Class A Ordinary Share
NASDAQ:CEPT
Market cap
$360.23M
Titan Acquisition Corp.
NASDAQ:TACH
Market cap
$360.18M
Questions
Filing questions
Common questions about MBVIU's filings, answered from its disclosures.
What is the latest MBVIU filing?
The latest filing shown is 3 dated May 19, 2026.
How many recent filings does MBVIU have?
Intrinsic Alpha currently shows 20 recent filings for MBVIU.
Continue the stock analysis
Jump to another research area for this company.